Stratos Wealth Partners’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,249
Closed -$392K 1383
2023
Q4
$392K Sell
1,249
-40
-3% -$14.5K 0.01% 969
2023
Q3
$572K Hold
1,289
0.01% 778
2023
Q2
$559K Sell
1,289
-49
-4% -$27.5K 0.01% 725
2023
Q1
$794K Sell
1,338
-84
-6% -$47K 0.02% 548
2022
Q4
$574K Hold
1,422
0.01% 685
2022
Q3
$833K Sell
1,422
-120
-8% -$71.9K 0.02% 536
2022
Q2
$842K Buy
1,542
+20
+1% +$10.1K 0.02% 559
2022
Q1
$965K Sell
1,522
-86
-5% -$44.3K 0.02% 568
2021
Q4
$1.08M Buy
+1,608
New +$978K 0.02% 533

Other funds holding AGL

Stratos Wealth Partners's AGL Position: Q1 2024 in Review

Stratos Wealth Partners sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 1,249 shares — an estimated $392K sold.

Stratos Wealth Partners first reported a position in AGL in Q4 2021 and held it in 9 quarters. The position peaked at $1.08M in Q4 2021. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Stratos Wealth Partners reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,249 Agilon Health shares in Q1 2024, an estimated $392K.
  • Stratos Wealth Partners first reported a position in Agilon Health in Q4 2021 and held it in 9 quarters.
  • Stratos Wealth Partners's Agilon Health position peaked at $1.08M in Q4 2021.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Stratos Wealth Partners's 13F filing for Q1 2024, filed 16 Apr 2024.